** Shares of medical device maker Medtronic MDT.N down 1.3% at $85.26 premarket
** MDT plans to separate its diabetes business into a stand-alone company within 18 months, the Wall Street Journal reports
** The new company, led by the head of Medtronic's diabetes division, will have around 8,000 employees, WSJ says
** As of last close, stock up 8.12% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.